Vertex Pharmaceuticals VRTX Change in Inventories
Change in Inventories at other companies
Other financials
Where this comes from
Reported directly by Vertex Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.
The official record: Vertex Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vertex Pharmaceuticals's change in inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vertex Pharmaceuticals's change in inventories?
- Vertex Pharmaceuticals (VRTX) reported change in inventories of $97.7M in Q1 2026.
- How has Vertex Pharmaceuticals's change in inventories changed year-over-year?
- Vertex Pharmaceuticals's change in inventories decreased by 41.5% year-over-year, from $167.1M to $97.7M.
- What is the long-term trend for Vertex Pharmaceuticals's change in inventories?
- Over 4 years (2021 to 2025), Vertex Pharmaceuticals's change in inventories has grown at a 54.2% compound annual growth rate (CAGR), from $92.8M to $524.2M.
- What does change in inventories mean?
- Increase or decrease in inventory levels, directly affecting operating cash flow and working capital.